Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrooks Macdonald Regulatory News (BRK)

Share Price Information for Brooks Macdonald (BRK)

Share Price is delayed by 15 minutes
Get Live Data
1,250.00    -15.00 (-1.19%)
Bid:
1,260.00
Ask:
1,295.00
Spread: 35.00 (2.778%)
Market Cap: £193.10m
BRK Live PriceLast checked at - London Stock Exchange

Intraday Brooks Macdonald Share Chart

Director/PDMR Shareholding

9 Nov 2022 09:22

RNS Number : 8286F
Brooks Macdonald Group PLC
09 November 2022
Β 

Brooks Macdonald Group PLC

(the "Company")

Β 

Director/PDMR Shareholding

Β 

Director's Shareholding

On 7 November 2022, Ben Thorpe, Chief Financial Officer of the Company, transferred, via sale and purchase, 14,290 ordinary shares of one pence each in the Company (the "Shares"). He sold 14,290 Shares at the price of Β£18.05 per Share from his personal investment account and bought 14,290 Shares at a price of Β£18.0530 per Share to be held in his personal ISA account

Β 

In addition, he also exercised awards over 5,243 shares granted under the 2018 Long Term Incentive Plan as deferred bonus share awards (the "Awards") in 2019, 2020 and 2021 as set out in the table below. Following the exercise, a total of 2,531 Shares were sold to meet the income tax and National Insurance liabilities due as a result of the exercise at a price of Β£19.172820 per share.

Β 

Awards

No. of share awards exercised

No. of shares sold

No. of shares retained

Deferred bonus 2019

1,589

767

822

Deferred bonus 2020

1,829

883

946

Deferred bonus 2021

1,825

881

944

Totals

5,243

2,531

2,712

Β 

To satisfy the exercise of the Awards, 5,243 Shares were transferred from the Brooks Macdonald Employee Benefit Trust (the "EBT"). The Company was notified by JTC Employer Solutions Trustee Limited, as trustees of the EBT, that following this transfer the EBT holds 595,879 Shares, representing 3.68% of the Company's total voting rights.

Β 

Β 

Enquiries:

Β 

Brooks Macdonald Group PLC

Andrew Shepherd, CEO

+44 (0)20 7659 3492

Ben Thorpe, CFO

+44 (0)20 7659 3492

Peel Hunt LLP

Paul Shackleton / John Welch

+44 (0)20 7418 8900

Β 

Β 

LEI: 213800WRDF8LB8MIEX37

Β 

Β 

Β 

ANNEX

The notification below, made in accordance with the UK Market Abuse Regulation, provides further details:

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Ben Thorpe

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β 

(a)

Name

Brooks Macdonald Group plc

(b)

LEI

213800WRDF8LB8MIEX37

Β 

Transaction 1

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Β 

Ordinary shares of 1 pence each

Β 

BRK

Β ISIN GB00B067N833Β 

(b)

Nature of the transaction

Sale of ordinary shares of 1 pence each in the Company

(c)

Price(s) and volume(s)

Volume: 14,290

Price(s): Β£18.05 per share

Β 

(d)

Aggregated information

Aggregated volume: 14,290

Aggregated price: Β£18.05

Date of the transaction

7 November 2022

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Β 

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Ben Thorpe

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β 

(a)

Name

Brooks Macdonald Group plc

(b)

LEI

213800WRDF8LB8MIEX37

Β 

Transaction 1

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Β 

Ordinary shares of 1 pence each

Β 

BRK

Β ISIN GB00B067N833Β 

(b)

Nature of the transaction

Purchase of ordinary shares of 1 pence each in the Company

(c)

Price(s) and volume(s)

Volume: 14,290

Price(s): Β£18.0530 per share

Β 

(d)

Aggregated information

Aggregated volume: 14,290

Aggregated price: Β£18.0530

Date of the transaction

7 November 2022

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Ben Thorpe

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β 

(a)

Name

Brooks Macdonald Group plc

(b)

LEI

213800WRDF8LB8MIEX37

Β 

Transaction 1

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Β 

Ordinary shares of 1 pence each

Β 

BRK

Β ISIN GB00B067N833Β 

(b)

Nature of the transaction

Exercise of awards granted under the 2019 Brooks Macdonald Long Term Incentive Plan as deferred bonus share awards

(c)

Price(s) and volume(s)

Volume: 5,243

Price(s): nil

Β 

(d)

Aggregated information

Aggregated volume: 5,243

Aggregated price: nil

Date of the transaction

7 November 2022

Place of the transaction

Outside a trading venue

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Ben Thorpe

2.

Reason for the notification

(a)

Position/status

Chief Financial OfficerΒ 

(b)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β 

(a)

Name

Brooks Macdonald Group plc

(b)

LEI

213800WRDF8LB8MIEX37

Β 

Transaction 1

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Β 

Ordinary shares of 1 pence each

Β 

BRK

Β ISIN GB00B067N833Β 

(b)

Nature of the transaction

Sale of shares to cover income tax and National Insurance liabilities due on exercise of awards granted under the 2019 Brooks Macdonald Long Term Incentive Plan as deferred bonus share awards

(c)

Price(s) and volume(s)

Volume: 2,531

Price(s): Β£19.172820

(d)

Aggregated information

Aggregated volume: 2,531

Aggregated price: Β£19.172820

Date of the transaction

7 November 2022

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHGCBDBGDGDGDC
Date   Source Headline
17th Sep 20212:08 pmRNSDirector/PDMR Shareholding
16th Sep 20217:00 amRNSFinal Results
2nd Sep 20214:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSTotal Voting Rights
2nd Aug 20217:00 amRNSTotal Voting Rights
20th Jul 20214:06 pmRNSHolding(s) in Company
15th Jul 20217:00 amRNSQuarterly Trading Update
8th Jul 20217:00 amRNSAppointment of Executive Directors
1st Jul 20217:00 amRNSTotal Voting Rights
23rd Jun 20215:23 pmRNSDirector/PDMR Shareholding
8th Jun 20219:59 amRNSBlock Listing Application
7th Jun 202110:51 amRNSDirector/PDMR Shareholding
7th Jun 20217:00 amRNSBlock listing Interim Review
1st Jun 202110:31 amRNSTotal Voting Rights
28th May 20217:00 amRNSDirectorate Change
26th May 20214:35 pmRNSPrice Monitoring Extension
20th May 20214:41 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
17th May 20217:00 amRNSAppointment of Chief Executive Officer
12th May 20215:17 pmRNSDirector/PDMR Shareholding
11th May 20213:28 pmRNSHolding(s) in Company
4th May 20212:54 pmRNSDirector/PDMR Shareholding
30th Apr 202110:00 amRNSTotal Voting Rights
28th Apr 20214:41 pmRNSSecond Price Monitoring Extn
28th Apr 20214:36 pmRNSPrice Monitoring Extension
15th Apr 20217:00 amRNSQuarterly Announcement of Funds under Management
13th Apr 20214:02 pmRNSHolding(s) in Company
9th Apr 20215:45 pmRNSHolding(s) in Company
9th Apr 20215:45 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
26th Mar 202111:47 amRNSDirector/PDMR Shareholding
25th Mar 20214:46 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSHalf-year Results
1st Feb 20216:12 pmRNSAIM Rule 17 Disclosure
1st Feb 202110:25 amRNSTotal Voting Rights
14th Jan 20217:00 amRNSQuarterly Announcement of Funds under Management
11th Jan 20217:00 amRNSHolding(s) in Company
31st Dec 202012:00 pmRNSTotal Voting Rights
7th Dec 20209:14 amRNSBlock listing Interim Review
3rd Dec 20205:42 pmRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSCompletion of Acquisition
30th Nov 20202:02 pmRNSTotal Voting Rights
24th Nov 20201:25 pmRNSDirector/PDMR Shareholding
19th Nov 20201:55 pmRNSAIM Rule 17 Disclosure
11th Nov 20209:58 amRNSHolding(s) in Company
10th Nov 20202:35 pmRNSDirector/PDMR Shareholding
2nd Nov 20204:27 pmRNSDirector/PDMR Shareholding
2nd Nov 20202:19 pmRNSTotal Voting Rights
27th Oct 202012:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.